KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueDepreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Teladoc Health (TDOC) Accumulated Depreciation & Amortization (2016 - 2025)

Teladoc Health's Accumulated Depreciation & Amortization history spans 12 years, with the latest figure at $85.2 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization rose 19.44% year-over-year to $85.2 million; the TTM value through Dec 2025 reached $85.2 million, up 19.44%, while the annual FY2025 figure was $85.2 million, 19.44% up from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $85.2 million at Teladoc Health, up from $71.4 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $85.2 million in Q4 2025 and bottomed at $34.1 million in Q4 2021.
  • The 5-year median for Accumulated Depreciation & Amortization is $59.7 million (2023), against an average of $59.6 million.
  • The largest annual shift saw Accumulated Depreciation & Amortization skyrocketed 55.38% in 2021 before it rose 19.44% in 2025.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $34.1 million in 2021, then surged by 39.79% to $47.7 million in 2022, then increased by 25.21% to $59.7 million in 2023, then grew by 19.45% to $71.4 million in 2024, then rose by 19.44% to $85.2 million in 2025.
  • Per Business Quant, the three most recent readings for TDOC's Accumulated Depreciation & Amortization are $85.2 million (Q4 2025), $71.4 million (Q4 2024), and $59.7 million (Q4 2023).